|Page tools: Print Page Print All|
APOLIPOPROTEIN B (Apo B)
Cut off points for Apo B in the NATSIHMS
Further test information about the analysis method and machine used to measure Apo B levels is available in Excel spreadsheet format in the Downloads page of this product.
The data items and related output categories for this topic are available in Excel spreadsheet format from the Downloads page of this product.
Points to be considered when interpreting data for this topic include the following:
Comparability with other surveys
The NATSIHMS is the first ABS Aboriginal and Torres Strait Islander survey to collect biomedical information. Given it was also the first national level survey (ABS or otherwise) to collect such data for the Aboriginal and Torres Strait Islander population, no comparisons with previous surveys for this population are possible.
However, biomedical data was also collected for all Australians in the 2011-12 National Health Measures Survey (NHMS) and information about comparisons between the NHMS results and those of non-ABS surveys is available from the Comparisons with other Australian surveys section of the Biomedical Results for Chronic Diseases, 2011-12 publication.
1 Barter PJ, Ballantyne CM, Carmena R, Castro Cabezas M, Chapman MJ, Couture P, de Graaf J, Durrington PN, Faergeman O, Frohlich J, Furberg CD, Gagne C, Haffner SM, Humphries SE, Jungner I, Krauss RM, Kwiterovich P, Marcovina S, Packard CJ, Pearson TA, Reddy KS, Rosenson R, Sarrafzadegan N, Sniderman AD, Stalenhoef AF, Stein E, Talmud PJ, Tonkin AM, Walldius G, Williams KM, 2006, Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel, Heart Research Institute, Journal of Internal Medicine, <http://www.ncbi.nlm.nih.gov/pubmed/16476102>, Last accessed 08/09/2014.
2 Heil W, Ehrhardt V, 2008, Reference Ranges for Adults and Children: Pre-Analytical Considerations, Roche Diagnostics GmbH, Mannheim, <https://www.rochediagnostics.fr/Htdocs/media/pdf/actualites/2a_Reference_Ranges_2008.pdf>, Last accessed 08/09/2014.
3 Appleton CA, Caldwell G, McNeil A, Meerkin M, Sikaris K, Sullivan DR, Thomas DW, and DP Tognarini, Australian Pathology Lipid Interest Group, 2007, Recommendations for Lipid Testing and Reporting by Australian Pathology Laboratories, <http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1904423/>, Last accessed 08/09/2014.
4 National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand, 2005, Position Statement on Lipid Management - 2005, <http://www.heartfoundation.org.au/sitecollectiondocuments/the-lipid-position-statement.pdf>, Last accessed 08/09/2014.
5 Friedewald WT, Levy RI, Fredrickson DS,1972, Estimation of the low-density lipoprotein cholesterol in plasma without use of preparative ultracentrifuge, <http://www.clinchem.org/content/18/6/499.full.pdf>, Last accessed 08/09/2014.